Tag: Altimmune

Altimmune finds itself at a critical juncture this quarter, with its shares potentially on the verge of a significant move. ...

Biotechnology firm Altimmune is witnessing a substantial rally in its share price following the release of impressive mid-stage clinical trial ...

This week represents a critical juncture for Altimmune as the biopharmaceutical company prepares to release its third-quarter 2025 financial results ...

Altimmune finds itself navigating turbulent waters as multiple class-action lawsuits cast a shadow over the company's stock performance. The litigation ...

Altimmune finds itself at a crossroads this week, presenting its investment case at the H.C. Wainwright Global Investment Conference while ...

Biopharmaceutical company Altimmune finds itself navigating turbulent waters as a shareholder class action lawsuit compounds challenges stemming from disappointing clinical ...